ACELYRIN $621 million IPO
The stock is listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Arlo Technologies IPO securities class action win upheld on appeal
We secured a dismissal for the IPO underwriters
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
Privia Health Group $936 million secondary offering
We advised Privia on the registered secondary offering
DexCom $1.25 billion convertible notes offering and capped call transactions
The 0.375% convertible senior notes are due 2028
Ocado Group acquisition of 6 River Systems
We are advising Ocado Group on the transaction
Clarios $750 million notes offering and $2.75 billion term loan
We advised Clarios International on the transactions
Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen
We are advising Cellular Biomedicine Group on the transaction
Advent International $2.25 billion Maxar Technologies acquisition financing
We advised the lenders on the facilities
Avaya emerges from chapter 11
We advised the prepetition term loan agent and escrow agent on the transaction